PTPN11 and neurofibromatosis type 1: NF1 is characterized by an extremely variable clinical spectrum, ranging from isolated skin manifestations to a more complex multi-system involvement, and approximately 10% of individuals with NF1 share phenotypic features with Noonan syndrome, a RASopathy caused in about half of patients by mutations in PTPN11 [16,26,27].